june 11 galileo room june 12 galileo room june 12 da vinci ... · language the official language is...

2
June 13 Galileo Room June 13 Da Vinci Room June 14 Da Vinci Room June 12 Galileo Room June 12 Da Vinci Room June 11 Galileo Room SESSION 1: SATELLITE SYMPOSIA 10.00 Symposium: NGAL Around the World Sponsored by Alere 13.00 Lunch 13.30 Symposium: Cardio-Renal Syndromes Sponsored by Fresenius Medical Care 15.00 Symposium: Management of AKI and recovery Sponsored by Gambro 16:30 Symposium: Fluid management in AKI and CRRT Sponsored by B. Braun 10.00 Symposium: Renal Denervaon Sponsored by St. Jude 11.30 Symposium: Contrast-induced AKI Sponsored by GE Healtcare 13.00 Lunch 13.30 Symposium: New trends in CRRT: a new system unveiled Sponsored by Asahi 15.00 Symposium: AKI Biomarkers of Risk Assessment: A New Age Sponsored by Astute 16:30 Symposium: Cardio-renal syndrome in neonates and chil- dren: New perspecves Sponsored by Bellco SESSION 2: OPENING CEREMONY 18.30 Crical Care Nephrology from origin to today C. Ronco 18.45 Internaonal “Vicenza” Award for Crical Care Nephrology 19.00 Lessons from Recent trials in Crical Care Nephrology R. Bellomo 19.20 Welcome Recepon SESSION 3A: EPIDEMIOLOGY OF AKI Chairmen: J. Kellum - G. Gerosa 8.00 AKI classificaon and the conceptual model of AKI J. Kellum 8.20 Epidemiology and outcomes of AKI in hospital and ICU E. Hoste 8.40 Incidence and outcomes of AKI in Sepsis and MOF J.L.Vincent 9.00 Incidence and outcomes of AKI in cardiac surgery N. Katz 9.20 Risk Factors for AKI in Hospital and ICU M. Rosner 9.40 The meaning of baseline creanine: results from a large Japanese database S. Uchino 10.00 Discussion 10.10 Coffee Break and Visit to the Exhibion SESSION 4A: AKI IN SEPSIS Chairmen: J.L. Vincent - R. Bellomo 10.40 The kidney in sepc AKI R. Bellomo 11.00 Sepsis, AKI and intra-renal shunng P. Calzavacca 11.20 Trials in sepsis: what about the kidney? J.L. Vincent 11.40 Starch and the kidney: the CHEST trial R. Bellomo 12.00 Is endotoxin the right target? M. Antonelli 12.20 Blood Purificaon in Sepsis: does it make sense? J. Kellum 12.40 Discussion 13.00 Lunch And Visit To The Exhibion SESSION 5A: RRT PRACTICE IN THE ICU Chairmen: I. Baldwin - M. Rosner 14.10 Evoluon of technology in CRRT C. Ronco 14.30 Timing of iniaon of RRT J. Kellum 14.50 Mode of connuous therapy: Hemofiltraon vs hemodialysis S. Bagshaw 15.10 RRT in elderly and octogenarians M. Rosner 15.30 The vascular access approach B. Canaud 15.50 Discussion 16.00 Coffee Break and Visit to the Exhibion SESSION 6A: CRRT TECHNOLOGY Chairmen: S. Goldstein - J. Kellum 16.30 The CRRT Machine: a multasking plaorm? W. Clark 16.50 Extracorporeal CO2 Removal P. Piccinni 17.10 Extracorporeal removal of Endotoxin M. Antonelli 17.30 CRRT fluid supply C. Ronco 17.50 AKI in pediatrics S. Goldstein 18.10 CRRT in Pediatrics Z. Ricci 18.30 Adjourn SESSION 3B: MOLECULAR BASES OF AKI Chairmen: G. Capasso - J. Bonventre 8.00 OMICS in AKI G. Capasso 8.20 Urine Analysis in AKI S. Bagshaw 8.40 Exosomes and AKI G. Camussi 9.00 Renal Dendric cells and AKI M. Okusa 9.20 Stem Cells and AKI P. Romagnani 9.40 Cell cycle arrest and maladapve repair in AKI J. Bonventre 10.00 Discussion 10.10 Coffee Break and Visit to the Exhibion SESSION 4B: KIDNEY AND HEART Chairmen: A. Shaw - B. Pieske 10.40 Acute Cardio-Renal Syndromes: bidireconal clinical enes M. Chawla 11.00 The kidney in Acute Coronary Syndromes (STEMi vs CRIAKI) C. Ronco 11.20 The Kidney in Heart Failure P. Mc Cullough 11.40 Pro-Enkephalin - A novel kidney dysfuncon marker A. Maisel 12.00 AKI in HF: systolic VS diastolic dysfuncon B. Pieske 12.20 AKI in cardiac surgery. A complete overview A. Shaw 12.40 Discussion 13.00 Lunch And Visit To The Exhibion SESSION 5B: AKI: MULTIDISCIPLINARY SYNDROME WITH ORGAN CROSSTALK Chairmen: M. Antonelli - H. Rabb 14.10 The changing paern of AKI: from single to mulple organ failure M. Okusa 14.30 The kidney and the Lung H. Rabb 14.50 The kidney and the liver R. Bellomo 15.10 The kidney and the brain A. Davenport 15.30 The Kidney and the gut G. Capasso 15.50 Discussion 16.00 Coffee Break and Visit to the Exhibion SESSION 6B: ELECTROLYTES AND THE KIDNEY Chairmen: J. Cerdà - M. Okusa 16.30 Chloride and the kidney R. Bellomo 16.50 AKI in acute Intoxicaons M. Joannidis 17.10 Hyponatremia in the crically ill: use of vaptans M. Rosner 17.30 Calcium and phosphate in AKI and CRRT J. Cerdà 17.50 Role of teams and team performance in managing renal fail- ure P. Barach 18.10 Discussion 18.30 Adjourn 8.20 LECTURE: Crical illness and aging J.L. Vincent SESSION 7A: FLUID MANAGEMENT IN THE CRITICALLY ILL Chairmen: C. Ronco - D. Payen 8.50 Fluids as drugs: reconciling results of recent RCTs J. Kellum 9.10 BIVA Guided Fluid management in AKI, CRS and CRRT: the 5B approach C. Ronco 9.30 Fluid management in the ICU R. Bellomo 9.50 Intravenous fluid Therapy: update on the colloid/crystalloid debate A. Shaw 10.10 Fluid and vasopressor management in sepsis: what target should we set? J. Prowle 10.30 Discussion 10.45 Coffee Break and Visit to the Exhibion SESSION 8A: FLUID ASSESSMENT IN THE CRITICALLY ILL Chairmen: J. Prowle - S. Di Somma 11.00 Use of BIVA in the emergency department F. Peacock 11.20 Use of diurecs in the crically ill and CRS D. Payen 11.40 Ultrafiltraon VS Diurecs in fluid overloaded paents G. Marenzi 12.00 Fluid management in the emergency room S. Di Somma 12.20 Goal Directed hemodynamics to prevent CSA-AKI N. Katz 12.40 Discussion 13.00 Lunch And Visit To The Exhibion SESSION 9A: MULTIPLE ORGAN SUBSTITUTION AND SUPPORT Chairmen: P. Honoré - M. Schetz 14.00 The concept of mulple organ support therapy (MOST) C. Ronco 14.20 Extracorporeal Endotoxin removal D. Cruz 14.40 Extracorporeal Lung support J. Kellum 15.00 Extracorporeal liver perfusion R. Bellomo 15.20 CRRT in Cardiac surgery associated AKI A. Shaw 15.40 Vicenza/Leeds Crical Care Nephrology model A. Lewington 16.00 Discussion 16.15 Coffee Break and Visit to the Exhibion SESSION 10A: CRITICAL CARE NEPHROLOGY ISSUES Chairmen: A. Lewington - N. Katz 16.30 Contrast induced AKI P. Mc Cullough 16.50 AKI in trauma and rhabddomyolysis P. Barach 17.10 AKI in cancer and hematological disorders T. Rimmelé 17.30 AKI in Burns P. Honorè 17.50 Potassium handling in Aki and cardio-renal paents G. Bakris 18.10 Discussion 18.30 Adjourn 8.20 LECTURE: Long term outcomes for the RENAL trial paents R. Bellomo SESSION 7B: AKI MECHANISMS AND PATTERNS OF CARE Chairmen: M. Chawla - P. Romagnani 8.50 Cell autophagy and AKI M. Schetz 9.10 Damps and Pamps J. Kellum 9.30 Human factors and its role in improving the safety and relia- bility of renal therapy P. Barach 9.50 Do Re Mi Fa Trial E. Kipnis 10.10 Renal Denervaon in Hypertensive paents B. Reimers 10.30 Discussion 10.45 Coffee Break and Visit to the Exhibion SESSION 8B: CLINCAL AND SUBCLINICAL AKI Chairmen: R. Bellomo - M. Haase 11.00 Idenficaon of AKI paents E. Hoste 11.20 The concept of subclinical AKI C. Ronco 11.40 Permissive hypofiltraon in AKI M. Chawla 12.00 How can we prevent the kidney aack? J. Kellum 12.20 What's my favourite biomarker for AKI M. Haase 12.40 Discussion 13.00 Lunch And Visit To The Exhibion SESSION 9B: TECHNIQUES OF CRRT Chairmen: A. Davenport - A. Kazory 14.00 Coupling filtraon with adsorpon T. Rimmelé 14.20 New techniques of RRT in the ICU P. Honoré 14.40 New Membranes and their use in CRRT W. Clark 15.00 Acid-Base control in CRRT J. Cerdà 15.20 Should citrate be the ancoagulaon of roune? A. Davenport 15.40 Dialysate and replacement fluid composion for RRT M. Schetz 16.00 Discussion 16.15 Coffee Break and Visit to the Exhibion SESSION 10B: NEW ASPECTS IN CRRT Chairmen: J. Cerdà - M. Kaushik 16.30 Low Dose CRRT S. Uchino 16.50 CRRT with high cut off membranes R. Bellomo 17.10 High Volume or low volume CRRT? D. Payen 17.30 Cocurrent vs coutercurrent CRRT J. C. Kim 17.50 Results from NICE: recommendaons A. Lewington 18.10 Discussion 18.30 Adjourn 8.20 DEBATE : Chaired by C. Ronco The K-DIGO Guidelines are very useful J. Kellum Guidelines are useless, especially the K-DIGO AKI guidelines R. Amerling SESSION 11B: NEW HORIZONS IN AKI Chairmen: G. Joynt - Z. Ricci 9.00 Anbioc traon in CRRT G. Joynt 9.30 Epigenecs and intensive care: can we control our genomic desny? A. Shaw 9.50 Bioarficial kidney: where are we? M. Chawla 10.10 Stem Cell Treatment of AKI: the ALLOCURE study N. Katz 10.30 Key advances in safety and reliability of renal failure care P. Barach 10.50 Discussion 11.10 Break and visit of the exhibion SESSION 12B: SATELLITE SYMPOSIUM 12.00 Symposium: Endotoxin Removal Sponsored by Toray 13.30 Closing and Farewell Party 8.20 LECTURE: Long-term kidney recovery aſter AKI requiring and not requiring RRT R. Wald SESSION 11A: THE PRACTICE OF RRT IN THE ICU Chairmen: D. Cruz - R. Amerling 9.00 Paent safety issues M. Kaushik 9.30 How perform CRRT without ancoagulaon I. Baldwin 9.50 Extracorporeal therapies are useful in sepsis D. Payen 10.10 Extracorporeal therapies are useless in sepsis M. Schetz 10.30 New acquisions in endotoxin adsorpon therapy (Euphas, Euphrates, Euphas 2) C. Ronco 10.50 Discussion 11.10 Break and visit of the exhibion SESSION 12A: BIOMARKERS AND AKI DIAGNOSIS Chairmen: M. Haase - P. Mc Cullough 11.30 Diagnosis of AKI: how do we combine biomarker results and risk predicon models? J. Prowle 11.50 Combined use of cardiac and renal Biomarkers D. Cruz 12.10 Can we document progression from AKI to CKD by Bi- omarkers P. Murray 12.30 Do we have recovery biomarkers? J. Kellum 12.50 What clinical pracce modificaons will come from bi- omarkers? M. Chawla 13.10 Discussion 13.30 Closing and Farewell Party Galileo Room Da Vinci Room Galileo Room

Upload: others

Post on 26-Aug-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: June 11 Galileo Room June 12 Galileo Room June 12 Da Vinci ... · LANGUAGE The official language is English. No simultaneous trans-lation will be offered. VENUE The course will be

June 13 Galileo Room June 13 Da Vinci Room June 14 Da Vinci Room

June 12 Galileo Room June 12 Da Vinci Room June 11 Galileo Room

SESSION 1: SATELLITE SYMPOSIA

10.00 Symposium: NGAL Around the World Sponsored by Alere 13.00 Lunch 13.30 Symposium: Cardio-Renal Syndromes Sponsored by Fresenius Medical Care 15.00 Symposium: Management of AKI and recovery Sponsored by Gambro 16:30 Symposium: Fluid management in AKI and CRRT Sponsored by B. Braun

10.00 Symposium: Renal Denervation Sponsored by St. Jude 11.30 Symposium: Contrast-induced AKI Sponsored by GE Healtcare 13.00 Lunch 13.30 Symposium: New trends in CRRT: a new system unveiled Sponsored by Asahi 15.00 Symposium: AKI Biomarkers of Risk Assessment: A New Age Sponsored by Astute 16:30 Symposium: Cardio-renal syndrome in neonates and chil- dren: New perspectives Sponsored by Bellco

SESSION 2: OPENING CEREMONY

18.30 Critical Care Nephrology from origin to today C. Ronco

18.45 International “Vicenza” Award for Critical Care Nephrology

19.00 Lessons from Recent trials in Critical Care Nephrology

R. Bellomo

19.20 Welcome Reception

SESSION 3A: EPIDEMIOLOGY OF AKI Chairmen: J. Kellum - G. Gerosa 8.00 AKI classification and the conceptual model of AKI J. Kellum 8.20 Epidemiology and outcomes of AKI in hospital and ICU

E. Hoste 8.40 Incidence and outcomes of AKI in Sepsis and MOF

J.L.Vincent 9.00 Incidence and outcomes of AKI in cardiac surgery N. Katz 9.20 Risk Factors for AKI in Hospital and ICU M. Rosner 9.40 The meaning of baseline creatinine: results from a large Japanese database S. Uchino 10.00 Discussion 10.10 Coffee Break and Visit to the Exhibition

SESSION 4A: AKI IN SEPSIS Chairmen: J.L. Vincent - R. Bellomo 10.40 The kidney in septic AKI R. Bellomo 11.00 Sepsis, AKI and intra-renal shunting P. Calzavacca 11.20 Trials in sepsis: what about the kidney? J.L. Vincent 11.40 Starch and the kidney: the CHEST trial R. Bellomo 12.00 Is endotoxin the right target? M. Antonelli 12.20 Blood Purification in Sepsis: does it make sense? J. Kellum 12.40 Discussion 13.00 Lunch And Visit To The Exhibition

SESSION 5A: RRT PRACTICE IN THE ICU Chairmen: I. Baldwin - M. Rosner 14.10 Evolution of technology in CRRT C. Ronco 14.30 Timing of initiation of RRT J. Kellum 14.50 Mode of continuous therapy: Hemofiltration vs hemodialysis

S. Bagshaw 15.10 RRT in elderly and octogenarians M. Rosner 15.30 The vascular access approach B. Canaud 15.50 Discussion 16.00 Coffee Break and Visit to the Exhibition

SESSION 6A: CRRT TECHNOLOGY Chairmen: S. Goldstein - J. Kellum 16.30 The CRRT Machine: a multitasking platform? W. Clark 16.50 Extracorporeal CO2 Removal P. Piccinni 17.10 Extracorporeal removal of Endotoxin M. Antonelli 17.30 CRRT fluid supply C. Ronco 17.50 AKI in pediatrics S. Goldstein 18.10 CRRT in Pediatrics Z. Ricci 18.30 Adjourn

SESSION 3B: MOLECULAR BASES OF AKI Chairmen: G. Capasso - J. Bonventre 8.00 OMICS in AKI G. Capasso 8.20 Urine Analysis in AKI S. Bagshaw 8.40 Exosomes and AKI G. Camussi 9.00 Renal Dendritic cells and AKI M. Okusa 9.20 Stem Cells and AKI P. Romagnani 9.40 Cell cycle arrest and maladaptive repair in AKI J. Bonventre 10.00 Discussion 10.10 Coffee Break and Visit to the Exhibition SESSION 4B: KIDNEY AND HEART Chairmen: A. Shaw - B. Pieske 10.40 Acute Cardio-Renal Syndromes: bidirectional clinical entities

M. Chawla 11.00 The kidney in Acute Coronary Syndromes (STEMi vs CRIAKI)

C. Ronco 11.20 The Kidney in Heart Failure P. Mc Cullough 11.40 Pro-Enkephalin - A novel kidney dysfunction marker A. Maisel 12.00 AKI in HF: systolic VS diastolic dysfunction B. Pieske 12.20 AKI in cardiac surgery. A complete overview A. Shaw 12.40 Discussion 13.00 Lunch And Visit To The Exhibition SESSION 5B: AKI: MULTIDISCIPLINARY SYNDROME WITH ORGAN CROSSTALK Chairmen: M. Antonelli - H. Rabb 14.10 The changing pattern of AKI: from single to multiple organ failure M. Okusa 14.30 The kidney and the Lung H. Rabb 14.50 The kidney and the liver R. Bellomo 15.10 The kidney and the brain A. Davenport 15.30 The Kidney and the gut G. Capasso 15.50 Discussion 16.00 Coffee Break and Visit to the Exhibition SESSION 6B: ELECTROLYTES AND THE KIDNEY Chairmen: J. Cerdà - M. Okusa 16.30 Chloride and the kidney R. Bellomo 16.50 AKI in acute Intoxications M. Joannidis 17.10 Hyponatremia in the critically ill: use of vaptans M. Rosner 17.30 Calcium and phosphate in AKI and CRRT J. Cerdà 17.50 Role of teams and team performance in managing renal fail- ure P. Barach 18.10 Discussion 18.30 Adjourn

8.20 LECTURE: Critical illness and aging J.L. Vincent

SESSION 7A: FLUID MANAGEMENT IN THE CRITICALLY ILL Chairmen: C. Ronco - D. Payen 8.50 Fluids as drugs: reconciling results of recent RCTs J. Kellum 9.10 BIVA Guided Fluid management in AKI, CRS and CRRT: the 5B approach C. Ronco 9.30 Fluid management in the ICU R. Bellomo 9.50 Intravenous fluid Therapy: update on the colloid/crystalloid debate A. Shaw 10.10 Fluid and vasopressor management in sepsis: what target should we set? J. Prowle 10.30 Discussion 10.45 Coffee Break and Visit to the Exhibition

SESSION 8A: FLUID ASSESSMENT IN THE CRITICALLY ILL Chairmen: J. Prowle - S. Di Somma 11.00 Use of BIVA in the emergency department F. Peacock 11.20 Use of diuretics in the critically ill and CRS D. Payen 11.40 Ultrafiltration VS Diuretics in fluid overloaded patients

G. Marenzi 12.00 Fluid management in the emergency room S. Di Somma 12.20 Goal Directed hemodynamics to prevent CSA-AKI N. Katz 12.40 Discussion 13.00 Lunch And Visit To The Exhibition

SESSION 9A: MULTIPLE ORGAN SUBSTITUTION AND SUPPORT Chairmen: P. Honoré - M. Schetz 14.00 The concept of multiple organ support therapy (MOST)

C. Ronco 14.20 Extracorporeal Endotoxin removal D. Cruz 14.40 Extracorporeal Lung support J. Kellum 15.00 Extracorporeal liver perfusion R. Bellomo 15.20 CRRT in Cardiac surgery associated AKI A. Shaw 15.40 Vicenza/Leeds Critical Care Nephrology model A. Lewington 16.00 Discussion 16.15 Coffee Break and Visit to the Exhibition

SESSION 10A: CRITICAL CARE NEPHROLOGY ISSUES Chairmen: A. Lewington - N. Katz 16.30 Contrast induced AKI P. Mc Cullough 16.50 AKI in trauma and rhabddomyolysis P. Barach 17.10 AKI in cancer and hematological disorders T. Rimmelé 17.30 AKI in Burns P. Honorè 17.50 Potassium handling in Aki and cardio-renal patients G. Bakris 18.10 Discussion 18.30 Adjourn

8.20 LECTURE: Long term outcomes for the RENAL trial patients R. Bellomo SESSION 7B: AKI MECHANISMS AND PATTERNS OF CARE Chairmen: M. Chawla - P. Romagnani 8.50 Cell autophagy and AKI M. Schetz 9.10 Damps and Pamps J. Kellum 9.30 Human factors and its role in improving the safety and relia- bility of renal therapy P. Barach 9.50 Do Re Mi Fa Trial E. Kipnis 10.10 Renal Denervation in Hypertensive patients B. Reimers 10.30 Discussion 10.45 Coffee Break and Visit to the Exhibition

SESSION 8B: CLINCAL AND SUBCLINICAL AKI Chairmen: R. Bellomo - M. Haase 11.00 Identification of AKI patients E. Hoste 11.20 The concept of subclinical AKI C. Ronco 11.40 Permissive hypofiltration in AKI M. Chawla 12.00 How can we prevent the kidney attack? J. Kellum 12.20 What's my favourite biomarker for AKI M. Haase 12.40 Discussion 13.00 Lunch And Visit To The Exhibition

SESSION 9B: TECHNIQUES OF CRRT Chairmen: A. Davenport - A. Kazory 14.00 Coupling filtration with adsorption T. Rimmelé 14.20 New techniques of RRT in the ICU P. Honoré 14.40 New Membranes and their use in CRRT W. Clark 15.00 Acid-Base control in CRRT J. Cerdà 15.20 Should citrate be the anticoagulation of routine?

A. Davenport 15.40 Dialysate and replacement fluid composition for RRT

M. Schetz 16.00 Discussion 16.15 Coffee Break and Visit to the Exhibition

SESSION 10B: NEW ASPECTS IN CRRT Chairmen: J. Cerdà - M. Kaushik 16.30 Low Dose CRRT S. Uchino 16.50 CRRT with high cut off membranes R. Bellomo 17.10 High Volume or low volume CRRT? D. Payen 17.30 Cocurrent vs coutercurrent CRRT J. C. Kim 17.50 Results from NICE: recommendations A. Lewington 18.10 Discussion 18.30 Adjourn

8.20 DEBATE : Chaired by C. Ronco The K-DIGO Guidelines are very useful J. Kellum Guidelines are useless, especially the K-DIGO AKI guidelines

R. Amerling SESSION 11B: NEW HORIZONS IN AKI Chairmen: G. Joynt - Z. Ricci 9.00 Antibiotic titration in CRRT G. Joynt 9.30 Epigenetics and intensive care: can we control our genomic destiny? A. Shaw 9.50 Bioartificial kidney: where are we? M. Chawla 10.10 Stem Cell Treatment of AKI: the ALLOCURE study N. Katz 10.30 Key advances in safety and reliability of renal failure care P. Barach 10.50 Discussion 11.10 Break and visit of the exhibition

SESSION 12B: SATELLITE SYMPOSIUM

12.00 Symposium: Endotoxin Removal Sponsored by Toray 13.30 Closing and Farewell Party

8.20 LECTURE: Long-term kidney recovery after AKI requiring and not requiring RRT R. Wald

SESSION 11A: THE PRACTICE OF RRT IN THE ICU Chairmen: D. Cruz - R. Amerling 9.00 Patient safety issues M. Kaushik 9.30 How perform CRRT without anticoagulation I. Baldwin 9.50 Extracorporeal therapies are useful in sepsis D. Payen 10.10 Extracorporeal therapies are useless in sepsis M. Schetz 10.30 New acquisitions in endotoxin adsorption therapy (Euphas, Euphrates, Euphas 2) C. Ronco 10.50 Discussion 11.10 Break and visit of the exhibition

SESSION 12A: BIOMARKERS AND AKI DIAGNOSIS Chairmen: M. Haase - P. Mc Cullough 11.30 Diagnosis of AKI: how do we combine biomarker results and risk prediction models? J. Prowle 11.50 Combined use of cardiac and renal Biomarkers D. Cruz 12.10 Can we document progression from AKI to CKD by Bi- omarkers P. Murray 12.30 Do we have recovery biomarkers? J. Kellum 12.50 What clinical practice modifications will come from bi- omarkers? M. Chawla 13.10 Discussion 13.30 Closing and Farewell Party

Galileo Room

Da Vinci Room

Galileo Room

Page 2: June 11 Galileo Room June 12 Galileo Room June 12 Da Vinci ... · LANGUAGE The official language is English. No simultaneous trans-lation will be offered. VENUE The course will be

GENERAL INFORMATION

LANGUAGE The official language is English. No simultaneous trans-lation will be offered.

VENUE The course will be held at Pavilion L of Vicenza Fair: Fiera di Vicenza - Padiglione L, Viale del Lavoro, 36100 Vicenza (Italy), on June 11-14, 2013.

REGISTRATION The registration fee is € 950 by April 30th 2013 and includes: congress kit, proceedings, attendance to scientific ses-sions. Registration fee after May 1st will be € 1050. After May 31st the registration will be possible on-site only.

The registration is possible:

ONLINE - www.vicenzanephrocourses.com

THROUGH BANK TRANSFER (see the Registration Form attached)

ONSITE

CANCELLATION 50% of the registration fee will be refunded by April 30th, 2013. There is no refund after May 1st, 2013. All cancellations must be submitted in writing by e-mail to

[email protected]

HOTEL ACCOMMODATION The course organizers will not arrange any hotel accommodation for participants. A complete list of hotels is available on the website with instructions for individual reserva-tion.

INDUSTRY EXHIBITION The Course will host on Industry Exhibition including the latest technology, equipment, pharmaceutical prod-ucts and literature. To discuss sponsorship opportunities and rates, please contact the Course Secretariat. The exhibition will be open all day long during the congress.

Endorsed by

The Vicenza International Courses are well renewed scientific events

held in the city of Andrea Palladio. Starting in 1982, international Vi-

cenza courses have been held regularly featuring an outstanding fac-

ulty and gathering participants from numerous countries. The themes

of Critical Care Nephrology, Hemodialysis and Peritoneal Dialysis have

been discussed with a 3 years rotation, leading to the most compre-

hensive review in the specific areas of practice and research. The

2013 edition of the course is dedicated to Critical Care Nephrology.

Previous editions of International Courses on Critical Care Nephrology

were held in 1998, 2001, 2004, 2007 and 2010. We gathered partici-

pants from more than 50 different countries. A series of lectures and

panel discussions were delivered during the three days of each course.

The proceedings were published in a special issue of Kidney Interna-

tional and in a special books of the series “Contributions to Nephrolo-

gy”. A widespread consensus on the format of the course and the

timely publication of the proceedings was recorded from the partici-

pants and a remarkably positive feedback was collected from physi-

cians, nurses and members of the industry of the field. For this rea-

son we decided to continue to host this course every three years;

sufficient time required in our opinion for a real advancement in tech-

nology and scientific knowledge and a sufficient accumulation of new

data. Our task is to put together specialists from different disciplines in

a single scientific event with a multidisciplinary approach to the criti-

cally ill patient with acute kidney injury and multiple organ dysfunc-

tion. The scientific quality of the course and its multidisciplinary nature

are guaranteed by the reputation of the faculty and the endorsement

of several scientific societies. We really hope that a large number of

delegates will join this important event which is becoming a classic

appointment for the experts and the physicians who want to receive

updated information in the field of Critical Care Nephrology. Compa-

nies and Members from the industry of the field are invited to join the

event reserving booth and spaces in the exhibition area.

Dr. Prof. Claudio Ronco

Meeting Planning and Organization

Mrs Anna Saccardo & Mrs Marta Scabardi

phone/fax +39 0444 753949

mobile +39 340 1607312

[email protected]

Administrative Secretariat

New Progress Service s.r.l.

Strada Scuole Anconetta 71

36100 Vicenza - ITALY

[email protected]

ABSTRACT SUBMISSION: Please submit your abstract using

Microsoft Word 2010 format on one A4 page using Times

New Roman font 14 for the title, names and affiliations (only

title in bold) and 12 for the body of the text.

Submit abstracts to [email protected]

Deadline: April 30th , 2013

RE

GIS

TR

AT

ION

FO

RM

SEN

D T

O: M

rs An

na Saccard

o an

d M

rs Marta Scab

ardi

fax +39

04

44

75

39

49

e-m

ail info

@irriv.co

m

DEA

DLIN

E: Ap

ril 30

th, 20

13

Att

en

de

e In

form

atio

n:

FIRST N

ame _

____

____

____

___

____

____

____

____

____

____

____

____

____

____

____

__ Gen

der: o

Male o

Female

LAST N

ame _

____

____

____

___

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

___

Co

un

try _____

____

____

____

____

____

____

____

____

____

____ C

ity ___

____

____

___

____

____

____

____

____

____

____

___

e-mail _

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

__

Invo

ice H

ead

er:

Nam

e ___

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

Ad

dress __

____

____

____

___

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

_

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

_

Co

un

try _____

____

____

____

____

____

____

____

____

____

____

____

____

____

_ ZIP C

od

e ____

____

____

____

____

___

____

Co

dice

Fiscale (fo

r Italia

n citi

zens) __

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

___

VA

T registrati

on

n°(if a

ny) _

___

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

___

ph

on

e _____

____

____

____

___

____

____

____

____

____

____

____

____

_ fax ____

____

___

____

____

____

____

____

____

___

e-mail __

____

____

___

____

___

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

___

I he

rew

ith e

nclo

se a co

py o

f Ban

k Transfe

r for a to

tal amo

un

t of €

95

0

Ne

w P

rogre

ss Service

s.r.l

Friulad

ria Cre

dit A

gricole

IBA

N: IT 2

6 H

05

33

6 1

18

32

00

00

40

09

07

22

BIC

: BP

PN

IT2P

19

1

Reg

istra

tion

for

ms d

uly co

mpiled

with

ou

t copy o

f ba

nk

tra

nsfer

will n

ot b

e accepted

DEC

LAR

ATIO

N - Yo

ur sign

ature is m

and

atory in

ord

er to p

rocess yo

ur registrati

on

!

Acco

rdin

g to th

e art. 13

D.Lgs 1

96

/200

3, N

ew P

rogress Service s.r.l are au

tho

rised to

use m

y perso

nal d

ata for p

urp

oses co

nn

ected

to C

on

gress

man

agemen

t, I also co

nfi

rm th

at I have u

nd

erstoo

d th

e cancellati

on

, paye

men

t and

refun

d p

olicy fo

r ind

ividu

al registratio

n sp

ecifi

ed in

ww

w.vicen

zan

eph

roco

urses.co

m

Date

, ___

____

____

___

Signatu

re __

____

____

____

____

____

____

____

____

____

___

Fiera Pad.L Vicenza - Italy

Regione Veneto - ULSS 6

Department of Nephrology, Dialysis and Renal Transplantation

San Bortolo Hospital - IRRIV International Renal Research Institute Vicenza

ABSTRACTS

WELCOME